Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Lewis

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Molecular Biochemistry|November 4, 2014
STAT3 Inhibition Induces Apoptosis in Cancer Cells Independent of STAT1 or STAT2Adetola Shodeinde, Kalyani Ginjupalli, H Dan Lewis, et al.
Molecular Cancer Therapeutics|June 21, 2008
STAT3 inhibition in prostate and pancreatic cancer lines by STAT3 binding sequence oligonucleotides: differential activity between 5' and 3' endsH Dan Lewis, Ashley Winter, Thomas F Murphy, et al.
BMC Biotechnology|October 30, 2010
Creation of a novel peptide with enhanced nuclear localization in prostate and pancreatic cancer cell linesH Dan Lewis, Ali Husain, Robert J Donnelly, et al.
Applied Physics Reviews|November 7, 2018
Stochasticity in materials structure, properties, and processing-A reviewRobert Hull, Pawel Keblinski, Dan Lewis, et al.
ACS ES&T Water|July 5, 2023
Predicting COVID-19 Infected Individuals in a Defined Population from Wastewater RNA DataChristopher S McMahan, Dan Lewis, Jessica A Deaver, et al.
Journal of the American College of Cardiology|January 15, 2002
Percutaneous coronary intervention versus coronary bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: The VA AWESOME multicenter registry: comparison with the randomized clinical trialDouglass A Morrison, Gulshan Sethi, Jerome Sacks, et al.
Journal of the American College of Cardiology|November 13, 2002
Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: outcome of diabetic patients in the AWESOME randomized trial and registrySteven P Sedlis, Douglass A Morrison, Jeffrey D Lorin, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Molecular Biochemistry|November 4, 2014
STAT3 Inhibition Induces Apoptosis in Cancer Cells Independent of STAT1 or STAT2Adetola Shodeinde, Kalyani Ginjupalli, H Dan Lewis, et al.
Molecular Cancer Therapeutics|June 21, 2008
STAT3 inhibition in prostate and pancreatic cancer lines by STAT3 binding sequence oligonucleotides: differential activity between 5' and 3' endsH Dan Lewis, Ashley Winter, Thomas F Murphy, et al.
BMC Biotechnology|October 30, 2010
Creation of a novel peptide with enhanced nuclear localization in prostate and pancreatic cancer cell linesH Dan Lewis, Ali Husain, Robert J Donnelly, et al.
Applied Physics Reviews|November 7, 2018
Stochasticity in materials structure, properties, and processing-A reviewRobert Hull, Pawel Keblinski, Dan Lewis, et al.
ACS ES&T Water|July 5, 2023
Predicting COVID-19 Infected Individuals in a Defined Population from Wastewater RNA DataChristopher S McMahan, Dan Lewis, Jessica A Deaver, et al.
Journal of the American College of Cardiology|January 15, 2002
Percutaneous coronary intervention versus coronary bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: The VA AWESOME multicenter registry: comparison with the randomized clinical trialDouglass A Morrison, Gulshan Sethi, Jerome Sacks, et al.
Journal of the American College of Cardiology|November 13, 2002
Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: outcome of diabetic patients in the AWESOME randomized trial and registrySteven P Sedlis, Douglass A Morrison, Jeffrey D Lorin, et al.
Pageof 2